SMTL ID : 8gsq.4 (4 other biounits)

Structure based studies reveal an atypical antipsychotic drug candidate - Paliperidone as a potent hSOD1 modulator with implications in ALS treatment.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

hetero-1-1-mer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain B: H.63, H.71, H.80, D.83, K.136 5 PLIP interactions: 5 interactions with chain B Metal complexes: B:H.63, B:H.71, B:H.80, B:D.83, B:D.83

1 x K4I: (9~{R})-3-[2-[4-(6-fluoranyl-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-9-oxidanyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one(Non-covalent)

K4I.2: 3 residues within 4Å: Chain B: K.30, W.32, D.96 7 PLIP interactions: 7 interactions with chain B Hydrophobic interactions: B:W.32 Water bridges: B:D.92 Salt bridges: B:D.96 pi-Stacking: B:W.32, B:W.32, B:W.32 Halogen bonds: B:K.30

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Aouti, S. et al., Structure-based discovery of an antipsychotic drug, paliperidone, as a modulator of human superoxide dismutase 1: a potential therapeutic target in amyotrophic lateral sclerosis. Acta Crystallogr D Struct Biol (2023)

Release Date

2023-06-14

Peptides

Superoxide dismutase [Cu-Zn]: A
Superoxide dismutase [Cu-Zn]: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
G

B
H

Superoxide dismutase [Cu-Zn]

Superoxide dismutase [Cu-Zn]

Related Entries With Identical Sequence